Join us at
Probiota Europe 2025

February 5-7, 2025
Copenaghen
(Bella Center)
Probiota Europe, the leading Microbiome industry event, uniting the realms of microbiome science and business
ibSium® - S. cerevisiae CNCM I-3856
ibSium® (Saccharomyces cerevisiae CNCM I-3856) is a patented probiotic yeast registered as Saccharomyces cerevisiae CNCM I-3856. Recognized as a reference probiotic strain, ibSium® has demonstrated its effectiveness in several rigorous clinical studies, showing that this yeast can significantly relieve gastrointestinal symptoms and improve overall quality of life.
Discover our market leadership human health
We have been building our expertise and market leadership in five key market segments, offering a portfolio of solutions that improve health and wellbeing throughout the entire body.
- Wellness & Immune Health: Immunity, Daily Nutrition, Cardiovascular Health, Beauty, and General Wellbeing
- Digestion & Gut Health: Microbiome Balance, Digestive Comfort, Liver Health Support
- Mobility & Joint Health: Bone Health, Joint Health, Muscle Health, and Sports Nutrition
- Reproduction & Women’s Health: Vaginal Care, Urinary Health, Fertility, Pregnancy, and Menopause
- Mood & Cognitive Health: Mood Health, Cognition, and Stress & Anxiety
Related articles

- MenaQ7®
- Mobility & Joint
- MyCondro®
- Apr 17, 2025
Successful Vital Nutrients Symposium:
Shaping the Future of Healthy Aging
The Vital Nutrients Symposium 2025, held in Kassel, Germany, offered an excellent platform to...

- MenaQ7®
- Mobility & Joint
- News
- Apr 09, 2025
Groundbreaking Vitamin K2 Research Presented at the 7th Osteoporosis Congress in Padova (March 19-21, 2025)
Gnosis recently took an important step in advancing the scientific understanding of vitamin K2...

- Emothion®
- News
- Wellness & Immune
- Apr 08, 2025
Emothion® Webinar Explores the Science for Skin Health
Gnosis by Lesaffre recently hosted a highly informative webinar titled "Emothion® Skin Health Redefined:...